Timothy Burgess

Timothy Burgess, M.D., M.P.H., is a Professor and Interim Chair of the Department of Preventive Medicine and Biostatistics at the Uniformed Services University (USU) School of Medicine. He also holds secondary appointments in the Departments of Medicine and Emerging Infectious Diseases. His work focuses on immune responses to viral pathogens and vaccine development.

• M.P.H., Uniformed Services University of the Health Sciences, 1999-2000
• Fellowship, Infectious Diseases, National Capitol Consortium, 1997-1999
• Residency, Internal Medicine, National Naval Medical Center, 1994-1997
• M.D., Indiana University School of Medicine, 1990-1994
• B.S. in Chemistry, U.S. Naval Academy, 1986-1990

Burgess's research spans infectious diseases, immunology, and epidemiology, with a focus on viral pathogens like dengue, influenza, and SARS-CoV-2. His projects aim to optimize vaccine development and clinical management strategies for infectious diseases. He has contributed to clinical guidelines and trials addressing viral outbreaks and immune responses in vulnerable populations.

His recent publications highlight trends in vectorborne disease prevention, vaccine immunogenicity, and antiviral therapies. Key areas include dengue prophylaxis, influenza treatment using convalescent plasma, and compliance with anti-vectorial measures in military deployments. Collaborations span institutions like the NIH and FDA.